Baillie Gifford & Co. Sells 84,123 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Baillie Gifford & Co. trimmed its position in Mettler-Toledo International Inc. (NYSE:MTD) by 46.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 97,005 shares of the medical instruments supplier’s stock after selling 84,123 shares during the period. Baillie Gifford & Co. owned approximately 0.46% of Mettler-Toledo International worth $145,478,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in MTD. Versor Investments LP bought a new position in Mettler-Toledo International in the 3rd quarter valued at about $1,755,000. Venturi Wealth Management LLC increased its holdings in Mettler-Toledo International by 47.7% during the 3rd quarter. Venturi Wealth Management LLC now owns 384 shares of the medical instruments supplier’s stock worth $576,000 after purchasing an additional 124 shares in the last quarter. Wolverine Asset Management LLC purchased a new stake in shares of Mettler-Toledo International in the third quarter worth approximately $750,000. Ashton Thomas Securities LLC bought a new position in shares of Mettler-Toledo International in the third quarter valued at approximately $37,000. Finally, Crossmark Global Holdings Inc. lifted its holdings in shares of Mettler-Toledo International by 39.1% in the third quarter. Crossmark Global Holdings Inc. now owns 2,531 shares of the medical instruments supplier’s stock valued at $3,796,000 after purchasing an additional 711 shares in the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.

Mettler-Toledo International Stock Down 4.6 %

Shares of MTD stock opened at $1,250.07 on Tuesday. The firm has a market cap of $26.53 billion, a P/E ratio of 33.70, a PEG ratio of 3.83 and a beta of 1.16. The company has a 50 day moving average of $1,394.23 and a 200-day moving average of $1,402.64. Mettler-Toledo International Inc. has a 12-month low of $1,015.29 and a 12-month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 532.25% and a net margin of 21.15%. The business had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. As a group, equities analysts expect that Mettler-Toledo International Inc. will post 40.34 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts recently commented on MTD shares. Robert W. Baird lowered their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday. JPMorgan Chase & Co. increased their target price on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a report on Monday, August 5th. Evercore ISI raised their price target on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Wells Fargo & Company reduced their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research report on Monday. Finally, Stifel Nicolaus dropped their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research report on Monday. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $1,338.75.

Insider Activity at Mettler-Toledo International

In related news, insider Christian Magloth sold 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the completion of the transaction, the insider now directly owns 734 shares of the company’s stock, valued at approximately $1,044,459.98. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.94% of the stock is currently owned by company insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.